Literature DB >> 21484473

Surgical technique: extraarticular knee resection with prosthesis-proximal tibia-extensor apparatus allograft for tumors invading the knee.

Rodolfo Capanna1, Guido Scoccianti, Domenico Andrea Campanacci, Giovanni Beltrami, Pietro De Biase.   

Abstract

BACKGROUND: Intraarticular extension of a tumor requires a conventional extraarticular resection with en bloc removal of the entire knee, including extensor apparatus. Knee arthrodesis usually has been performed as a reconstruction. To avoid the functional loss derived from the resection of the extensor apparatus, a modified technique, saving the continuity of the extensor apparatus, has been proposed, but at the expense of achieving wide margins. In tumors involving the joint cavity, the entire joint complex including the distal femur, proximal tibia, the full extensor apparatus, and the whole inviolated joint capsule must be excised. We propose a novel reconstructive technique to restore knee function after a true extrarticular resection. DESCRIPTION OF TECHNIQUE: The approach involves a true en bloc extraarticular resection of the whole knee, including the entire extensor apparatus. We performed the reconstruction with a femoral megaprosthesis combined with a tibial allograft-prosthetic composite with its whole extensor apparatus (quadriceps tendon, patella, patellar tendon, and proximal tibia below the anterior tuberosity). PATIENTS AND METHODS: We retrospectively reviewed 14 patients (seven with bone and seven with soft tissue tumors) who underwent this procedure from 1996 to 2009. Clinical and radiographic evaluations were performed using the MSTS-ISOLS functional evaluation system. The minimum followup was 1 year (average, 4.5 years; range, 1-12 years).
RESULTS: We achieved wide margins in 13 patients (two contaminated), and marginal in one. There were three local recurrences, all in the patients with marginal or contaminated resections. Active knee extension was obtained in all patients, with an extensor lag of 0° to 15° in primary procedures. MSTS-ISOLS scores ranged from 67% to 90%. No patients had neurovascular complications; two patients had deep infections.
CONCLUSIONS: Combining a true knee extraarticular resection with an allograft-prosthetic composite including the whole extensor apparatus generally allows wide resection margins while providing a mobile knee with good extension in patients traditionally needing a knee arthrodesis. LEVEL OF EVIDENCE: Level IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2011        PMID: 21484473      PMCID: PMC3171529          DOI: 10.1007/s11999-011-1882-2

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  19 in total

1.  Extensor mechanism allografts in total knee arthroplasty.

Authors:  D G Nazarian; R E Booth
Journal:  Clin Orthop Relat Res       Date:  1999-10       Impact factor: 4.176

2.  Resection-arthrodesis for malignant and potentially malignant lesions about the knee using an intramedullary rod and local bone grafts.

Authors:  W F Enneking; P D Shirley
Journal:  J Bone Joint Surg Am       Date:  1977-03       Impact factor: 5.284

3.  Knee reconstruction with prosthesis and muscle flap after total arthrectomy.

Authors:  P Anract; G Missenard; C Jeanrot; V Dubois; B Tomeno
Journal:  Clin Orthop Relat Res       Date:  2001-03       Impact factor: 4.176

4.  Limb-sparing surgery for high-grade malignant tumors of the proximal tibia. Surgical technique and a method of extensor mechanism reconstruction.

Authors:  M M Malawer; K A McHale
Journal:  Clin Orthop Relat Res       Date:  1989-02       Impact factor: 4.176

5.  Extra-articular wide tumor resection and limb reconstruction in malignant bone tumors invading the knee joint.

Authors:  S Nakamura; K Kusuzaki; H Murata; H Takeshita; M Hirata; S Hashiguchi; Y Hirasawa
Journal:  Oncol Rep       Date:  2001 Mar-Apr       Impact factor: 3.906

6.  Recommendations for the reporting of bone tumors. Association of Directors of Anatomic and Surgical Pathology.

Authors:  Fadi W Abdul-Karim; Thomas W Bauer; Scott E Kilpatrick; Kevin A Raymond; Gene P Siegal
Journal:  Hum Pathol       Date:  2004-10       Impact factor: 3.466

7.  Extraarticular knee resection for sarcomas with preservation of the extensor mechanism: surgical technique and review of cases.

Authors:  Pawel Zwolak; Stefanie P Kühnel; Bruno Fuchs
Journal:  Clin Orthop Relat Res       Date:  2010-04-24       Impact factor: 4.176

8.  Allograft prosthetic composite arthroplasty for osteosarcoma and other aggressive bone tumors.

Authors:  S Gitelis; P Piasecki
Journal:  Clin Orthop Relat Res       Date:  1991-09       Impact factor: 4.176

9.  Knee resection arthrodesis with allograft: a long-term follow-up study.

Authors:  R Casadei; D Donati; A Ferraro; S Giacomini; E Gozzi; M Gigli; F Boni; M Mercuri
Journal:  Chir Organi Mov       Date:  2003 Apr-Jun

10.  A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system.

Authors:  W F Enneking; W Dunham; M C Gebhardt; M Malawar; D J Pritchard
Journal:  Clin Orthop Relat Res       Date:  1993-01       Impact factor: 4.176

View more
  15 in total

Review 1.  Imaging following surgery for primary appendicular bone tumours.

Authors:  Imran Khan; Craig Gerrand; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2021-01-22       Impact factor: 2.199

Review 2.  Megaprosthesis versus Allograft Prosthesis Composite for massive skeletal defects.

Authors:  Deepak Gautam; Rajesh Malhotra
Journal:  J Clin Orthop Trauma       Date:  2017-09-25

3.  Proximal Tibia Reconstruction After Bone Tumor Resection: Are Survivorship and Outcomes of Endoprosthetic Replacement and Osteoarticular Allograft Similar?

Authors:  Jose I Albergo; Czar L Gaston; Luis A Aponte-Tinao; Miguel A Ayerza; D Luis Muscolo; Germán L Farfalli; Lee M Jeys; Simon R Carter; Roger M Tillman; Adesegun T Abudu; Robert J Grimer
Journal:  Clin Orthop Relat Res       Date:  2017-03       Impact factor: 4.176

Review 4.  Proximal femur versus acetabular extra-articular resection of the hip joint for primary malignant bone tumors: a retrospective comparative review of 33 cases.

Authors:  Victor Housset; Philippe Anract; Antoine Babinet; Guillaume Auberger; David Biau
Journal:  World J Surg Oncol       Date:  2022-05-28       Impact factor: 3.253

5.  What was the survival of megaprostheses in lower limb reconstructions after tumor resections?

Authors:  Rodolfo Capanna; Guido Scoccianti; Filippo Frenos; Antonio Vilardi; Giovanni Beltrami; Domenico Andrea Campanacci
Journal:  Clin Orthop Relat Res       Date:  2015-03       Impact factor: 4.176

Review 6.  [Endoprosthetic tumor replacement : Reconstruction of the extensor mechanism and complications].

Authors:  F Wilken; I J Banke; M Hauschild; S Winkler; K Schott; M Rudert; R V Eisenhart-Rothe
Journal:  Orthopade       Date:  2016-05       Impact factor: 1.087

7.  Finn/Orthopaedic Salvage System Distal Femoral Rotating-Hinge Megaprostheses in Oncologic Patients: Long-Term Complications, Reoperations, and Amputations.

Authors:  Koichi Ogura; Mohamed A Yakoub; Patrick J Boland; John H Healey
Journal:  J Bone Joint Surg Am       Date:  2021-04-21       Impact factor: 5.284

8.  Tips and tricks of limb salvage: Proximal tibia.

Authors:  Ajay Puri
Journal:  Indian J Orthop       Date:  2014-05       Impact factor: 1.251

9.  lower limbs kinematic assessment of the effect of a gym and hydrotherapy rehabilitation protocol after knee megaprosthesis: a case report.

Authors:  Nicola Lovecchio; Luciana Sciumè; Matteo Zago; Lorenzo Panella; Maurizio Lopresti; Chiarella Sforza
Journal:  J Phys Ther Sci       Date:  2016-03-31

Review 10.  Is superior tibiofibular joint resection necessary in extraarticular knee resection for sarcomas? A systematic review.

Authors:  Magdalena M Gilg; Christine Wibmer; Dimosthenis Andreou; Patrick Sadoghi; Georg Gosheger; Andreas Leithner
Journal:  World J Surg Oncol       Date:  2016-02-03       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.